Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · July 14, 2014

Off-Label Medication Use in Frontotemporal Dementia and Alzheimer's Disease

Alzheimer Disease and Associated Disorders

 

Additional Info

Alzheimer Disease and Associated Disorders
Demographic and Neuropsychiatric Factors Associated With Off-Label Medication Use in Frontotemporal Dementia and Alzheimer's Disease
Alzheimer Dis Assoc Disord 2014 Apr 01;28(2)182-189, MC Tartaglia, B Hu, K Mehta, J Neuhaus, K Yaffe, BL Miller, A Boxer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading